Reiss-Clark Cindy's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed Aug 24, 2023
- Accession no.
- 0001562180-23-006564
- Filed
- Aug 24, 2023
- Trade date
- Aug 22, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.37M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reiss-Clark CindyCIK 0001916513 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 22, 2023 | Common Stock | MOption exerciseAcquired | +1,112 | $173.22 | +$192,620.64 | 5,432.16 | Direct | |
| Aug 22, 2023 | Common Stock | MOption exerciseAcquired | +1,588 | $274.29 | +$435,572.52 | 7,020.16 | Direct | |
| Aug 22, 2023 | Common Stock | MOption exerciseAcquired | +777 | $369.13 | +$286,814.01 | 7,797.16 | Direct | |
| Aug 22, 2023 | Common Stock | SSaleDisposed | −3,477 | $393.34 | −$1,367,643.18 | 4,320.16 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 22, 2023 | Common Stock | MOption exerciseDisposed | −777 | $393.34 | −$305,625.18 | 2,331 | Direct | |
| Aug 22, 2023 | Common Stock | MOption exerciseDisposed | −1,588 | $393.34 | −$624,623.92 | 1,588 | Direct | |
| Aug 22, 2023 | Common Stock | MOption exerciseDisposed | −1,112 | $393.34 | −$437,394.08 | 1,756 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.